A randomized phase 1 study analyzing safety and efficacy of Deutetrabenazine in healthy volunteers
Latest Information Update: 14 Jun 2023
At a glance
- Drugs Deutetrabenazine (Primary)
- Indications Chorea; Drug-induced dyskinesia; Dyskinesias; Gilles de la Tourette's syndrome
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 14 Jun 2023 New trial record
- 27 Apr 2023 Results presented at the 75th Annual Meeting of the American Academy of Neurology 2023